Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

CER Daily Newsfeed

NPC's CER Daily Newsfeed® is your only daily source for the latest news and information on comparative effectiveness research.

Bookmark this webpage to check the postings each day, or sign up online to receive the updates via email. Questions or comments? Let us know!

Blog Post

CER Tweets of the Week: The State of Accountable Care, JAMA on PCORI’s Perspective, Real-World Impact of CER (October 13-17)

Health care stakeholders tweeted about accountable care, patient-centered outcomes research (PCOR) and the real-world impact of comparative...
Blog Post

CER Tweets of the Week: Health Affairs on the High Value of Specialty Medications, Pediatric CER Guidelines, Patient Heterogeneity (October 6-10)

This week, comparative effectiveness research (CER) stakeholders tweeted articles about specialty medications, CER guidelines and individual...
Blog Post

CER Tweets of the Week: Reports on Health Care Quality, Fellowships, and PCORI Turns 4

A report on health care quality from the U.S. Department of Health and Human Services, postdoctoral fellowships and the Patient-Centered Outcomes...
Blog Post

CER Tweets of the Week: Patient Engagement a Common Theme Among CER Stakeholders (September 22-26)

Patient engagement was a hot topic among comparative effectiveness research (CER) stakeholders on Twitter this week. @SUMedicine bioethicist David...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Press Release

NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon

(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use of comparative effectiveness research...
Press Release

CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools

(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important guidance to aid formulary decision-makers...
Press Release

New Peer-Reviewed Study Shows Mixed Results in ACO Medication Readiness To Achieve Quality, Cost Goals

Washington, D.C.—As Accountable Care Organizations (ACOs) gain traction among both private and public payers, so do expectations that these networks...
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health technology assessments are incorporating...
YouTube Videos

Health Technology Assessments and Specialty Medications

David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often challenges in conducting health technology...
YouTube Videos

Differences in Global Health Technology Assessment

David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology assessment (HTA) informs policy and...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
Blog Post

CER Tweets of the Week: The State of Accountable Care, JAMA on PCORI’s Perspective, Real-World Impact of CER (October 13-17)

Health care stakeholders tweeted about accountable care, patient-centered outcomes research (PCOR) and the real-world impact of comparative...
Blog Post

CER Tweets of the Week: Health Affairs on the High Value of Specialty Medications, Pediatric CER Guidelines, Patient Heterogeneity (October 6-10)

This week, comparative effectiveness research (CER) stakeholders tweeted articles about specialty medications, CER guidelines and individual...
Blog Post

CER Tweets of the Week: Reports on Health Care Quality, Fellowships, and PCORI Turns 4

A report on health care quality from the U.S. Department of Health and Human Services, postdoctoral fellowships and the Patient-Centered Outcomes...
Blog Post

CER Tweets of the Week: Patient Engagement a Common Theme Among CER Stakeholders (September 22-26)

Patient engagement was a hot topic among comparative effectiveness research (CER) stakeholders on Twitter this week. @SUMedicine bioethicist David...

Research

  •  
  • 1 of 14
  • >

Commentary & Testimony